Eric Delbridge
Private Equity Investor bij Sofinnova Investments, Inc.
Oorsprong van het eerstegraads netwerk van Eric Delbridge
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California.
30
| Private Company | Investment Managers | 30 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Eric Delbridge via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| INTERMUNE INC | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer Director/Board Member Director/Board Member | |
| HUMANIGEN, INC. | Biotechnology | Sales & Marketing Chairman | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| ACLARIS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Undergraduate Degree Graduate Degree | |
| OCERA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Yale University | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
| The University of Colorado | College/University | Undergraduate Degree Corporate Officer/Principal | |
| Sofinnova Management VI LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Amplyx Pharmaceuticals, Inc.
 Amplyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amplyx Pharmaceuticals, Inc. develops broad-spectrum antifungal agents for the treatment of life-threatening fungal infections. The firm's compound APX001, shows broad-spectrum activity in animal models of invasive fungal infection by common species of Candida and Aspergillus. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics. The company was founded by André Marquis, Mitchell W. Mutz and Gerry Crabtree in 2006 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The University of Texas Southwestern Medical Center | College/University | Corporate Officer/Principal Graduate Degree | |
JPMorgan Private Capital Asia Corp.
 JPMorgan Private Capital Asia Corp. Investment ManagersFinance JPMorgan Private Capital Asia Corp (JPMorgan Asia) is a private equity arm of JPMorgan Chase Co founded in 2006. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
| University of California | College/University | Doctorate Degree Doctorate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| Perelman School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| SPARK THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| Columbia University College of Physicians & Surgeons | College/University | Doctorate Degree | |
| BOLT BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dauntless 1, Inc.
 Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 1, Inc. engages in pharmaceuticals. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dauntless Pharmaceuticals, Inc.
 Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Dauntless Pharmaceuticals, Inc. develops specialty therapeutics via a one-asset, one-company model that is structured to facilitate operational efficiencies. The company was founded by Joel F. Martin and Michael F. Powell in May 2015 and is headquartered in San Diego, CA. | Drugstore Chains | Director/Board Member Founder | |
Xylocor Therapeutics, Inc.
 Xylocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xylocor Therapeutics, Inc. engages in the biopharmaceutical company that develops gene therapy for people with advanced coronary artery disease. It focuses on developing product for patients with refractory angina with no treatment options and its secondary product for patients with cardiac tissue damage from heart attacks. The company was founded by Ronald Crystal and Todd Rosengart in 2013 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Dauntless 2, Inc.
 Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Dauntless 2, Inc. operates in the healthcare industry focused on pharmaceutical business. The company is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Pionyr Immunotherapeutics, Inc.
 Pionyr Immunotherapeutics, Inc. BiotechnologyHealth Technology Pionyr Immunotherapeutics, Inc. develops cancer immunotherapies. It targets the tumor microenvironment to enhance the body?s antitumor immunity. The company was founded by Max Krummel and Sachdev Sidhu in 2015 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Aeovian Pharmaceuticals, Inc.
 Aeovian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aeovian Pharmaceuticals, Inc. engages in the development of pharmaceuticals. It offers inhibitors for the treatment of rare and age-related diseases. The company was founded by Stelios T. Tzannis in 2012 and is headquartered in Novato, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Director/Board Member | |
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Quanta Therapeutics, Inc. develops biotechnologies. The American company was founded in 2018 by Cameron Pitt, Frank McCormick. Perry D. Nisen has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Founder | |
| AEROVATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Biotechnology | Director/Board Member Chairman | |
Sofinnova Investments, Inc. (Investment Management)
 Sofinnova Investments, Inc. (Investment Management) Investment ManagersFinance Sofinnova Investments, Inc. (Investment Management) (Sofinnova-IM) is the investment management division of Sofinnova Investments, Inc., a venture capital firm headquartered in Menlo Park, California. Founded in 1974, Sofinnova-IM serves as an investment adviser to pooled investment vehicles and separately managed accounts. | Investment Managers | Chief Executive Officer Analyst-Equity | |
| CINCOR PHARMA, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Intrepida Bio, Inc.
 Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Intrepida Bio, Inc. discovers and develops medicines to modulate the innate immune system to fight cancer and other diseases. The company was founded by Joel F. Martin and Olivier Laurent and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Biotechnology | Director/Board Member | |
| VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 45 |
| Verenigd Koninkrijk | 3 |
| Ierland | 2 |
| Denemarken | 2 |
| Nederland | 2 |
Sectoraal
| Health Technology | 32 |
| Consumer Services | 13 |
| Commercial Services | 3 |
| Finance | 3 |
| Retail Trade | 2 |
Operationeel
| Director/Board Member | 161 |
| Independent Dir/Board Member | 56 |
| Corporate Officer/Principal | 56 |
| Private Equity Investor | 30 |
| Chairman | 27 |
Sterkste connecties
| Insiders | |
|---|---|
| James Healy | 50 |
| Michael Powell | 48 |
| David Kabakoff | 30 |
| Alan Colowick | 30 |
| Maha Katabi | 28 |
| Lars Ekman | 21 |
| Anand Mehra | 18 |
| Jakob Dupont | 14 |
| Jonathan Leff | 14 |
| Perry Nisen | 12 |
| Jason Pitts | 9 |
| James Brody | 9 |
| Raymond Bower | 8 |
| Debbie Murray | 7 |
| Sarah Bhagat | 6 |
- Beurs
- Insiders
- Eric Delbridge
- Bedrijfsconnecties
